Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

  • Lyme disease: pharmacists can helpSubscription

    By

    In recent years the awareness and, indeed, incidence of Lyme disease, a zoonotic tick borne condition, has increased steadily in the UK. Between 2001 and 2010 the number of confirmed cases of Lyme disease in Scotland soared from 28 to 308, although experts believe the true figure could be 10 times that number. Rates are more than three times higher in Scotland than in England.

  • We have a responsibility to actSubscription

    I was interested to read a view of climate scepticism in The Pharmaceutical Journal (PJ, 14 June 2014, p607). There is only controversy on this subject in the political sphere, with 97% of climate scientists agreeing that global warming is real, as well as every university and government in the world.

  • Packaging needs to be taken into accountSubscription

    By

    Although the research that has been done on the packaging issue is a step in the right direction, I believe the variation of packaging of the same product should also be taken into account.

  • Propagation of myth and confusionSubscription

    By

    Leading clinicians have written an open letter to NICE, outlining six major concerns requesting NICE to withdraw its recommendations for lowering the risk threshold for primary prevention. 

  • Using licensed productsSubscription

    By

    The National Institute for Health and Care Excellence has issued draft public health guidance relating to the growing problem of vitamin D deficiency and insufficiency in the UK. The draft guidance fails to make clear the importance of using licensed vitamin D products to fill prescriptions and, eventually, for over-the-counter sales, whenever possible. 

  • Not just a voice for the professionSubscription

    By

    The Pharmaceutical Journal, through its editorial freedoms and fiercely defended independence, has always sought to continue to meet the needs of members now and in the future.

  • Pharmacy degree must evolve to meet the needs of societySubscription

    By

    The comment article by Chijioke Agomo was an interesting and informative contribution to the discussion on the maintenance of pharmacist employment (PJ 2014;292:638). However, it did lack positive responses to the increasing problem that he identified.

  • Theory alone is obviously surpassed by clinical evidenceSubscription

    By

    I would like to make clear that I take no issue with the proactive identification of potential safety concerns, as suggested by the UKCPA group. The opening sentence in my letter should have made that clear

  • Disappointing turnoutSubscription

    By

    I was disappointed to read that only 9.33% of eligible Royal Pharmaceutical Society members voted in England in the recent national pharmacy board elections. The figure was double in Scotland and Wales.

  • Primum non nocereSubscription

    By , Hasanin Khachi, , , , ,

    We welcome the comments from Stuart Hill providing a counter-argument to the concerns initially raised by the UK Clinical Pharmacy Association Respiratory Group about Relvar Ellipta.

  • Pessimist or realist?Subscription

    By

    I am writing in response to the Leading article in The Pharmaceutical Journal (2014;292:472) entitled “Excellence prescribed”. This refers to the evidence and subsequent roundtable session held by the Scottish Parliament’s Health and Sport Committee on 29 April 2014.

  • Does nothing ever change?Subscription

    By

    I recall when I was at college 50 years ago, we were lectured on the dangers of microbial resistance to antibiotics and, unless care was taken in their use, we would end up in a situation where we would be left with nothing in our arsenal.

  • Not a prioritySubscription

    By

    I consider the Agenda in the The Journal (24/31 May 2014, p545) “Time to act: pharmacists must be prepared for environmental changes” to be controversial.

  • Dosing and complianceSubscription

    By

    There appears to be a contradiction in the opening and closing paragraphs of Stuart Hill’s letter. In the first paragraph he criticises concerns over comparative potencies of corticosteroids as being “theoretical” and not evidence based but, in his final sentence, he suggests that once-daily dosing will improve compliance.

  • Opportunities to promote self careSubscription

    By , , ,

    We welcome the article by Amisha Patel and Hemant Patel (PJ 2014;292:484), which focuses on self care of long-term conditions, how healthcare professionals should engage with it and the role community pharmacy should have in promoting this.

  • A key enabler of our futureSubscription

    By ,

    There has been a lot of discussion about pharmacist access to the electronic patient record. This has been acknowledged by health secretary Jeremy Hunt and to date has focused on read-only access to summary care records.

More from Correspondence

Newsletter Sign-up

Get the latest emails sent to your inbox.

Jobs from PJ careers

More jobs